Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Hirashima T, Kanai T, Suzuki H, Yoshida H, Matsushita A, Kawasumi H, Samejima Y, Noda Y, Nasu S, Tanaka A, Morishita N, Hashimoto S, Kawahara K, Tamura Y, Okamoto N, Tanaka T. Hirashima T, et al. Among authors: yoshida h. Anticancer Res. 2019 Nov;39(11):6231-6240. doi: 10.21873/anticanres.13832. Anticancer Res. 2019. PMID: 31704852
Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents.
Takata S, Koh G, Han Y, Yoshida H, Shiroyama T, Takada H, Masuhiro K, Nasu S, Morita S, Tanaka A, Hashimoto S, Uriu K, Suzuki H, Tamura Y, Okamoto N, Nagai T, Hirashima T. Takata S, et al. Among authors: yoshida h. J Infect Chemother. 2019 Jan;25(1):54-58. doi: 10.1016/j.jiac.2018.06.016. Epub 2018 Jul 25. J Infect Chemother. 2019. PMID: 30055859 Free article.
Significance of Quantitative Interferon-gamma Levels in Non-small-cell Lung Cancer Patients' Response to Immune Checkpoint Inhibitors.
Kanai T, Suzuki H, Yoshida H, Matsushita A, Kawasumi H, Samejima Y, Noda Y, Nasu S, Tanaka A, Morishita N, Hashimoto S, Kawahara K, Tamura Y, Okamoto N, Tanaka T, Hirashima T. Kanai T, et al. Among authors: yoshida h. Anticancer Res. 2020 May;40(5):2787-2793. doi: 10.21873/anticanres.14251. Anticancer Res. 2020. PMID: 32366425
Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study.
Hirashima T, Nagai T, Shigeoka H, Tamura Y, Yoshida H, Kawahara K, Kondoh Y, Sakai K, Hashimoto S, Fujishima M, Shiroyama T, Tamiya M, Morishita N, Suzuki H, Okamoto N, Kawase I. Hirashima T, et al. Among authors: yoshida h. BMC Cancer. 2014 Oct 18;14:770. doi: 10.1186/1471-2407-14-770. BMC Cancer. 2014. PMID: 25326267 Free PMC article.
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR).
Kitajima H, Tamura Y, Yoshida H, Kinoshita H, Katsuta H, Matsui C, Matsushita A, Arai T, Hashimoto S, Iuchi A, Hirashima T, Morishita H, Matsuoka H, Tanaka T, Nagai T. Kitajima H, et al. Among authors: yoshida h. J Clin Virol. 2021 Jun;139:104813. doi: 10.1016/j.jcv.2021.104813. Epub 2021 Mar 26. J Clin Virol. 2021. PMID: 33848785 Free PMC article.
7,989 results